MedPath

Randomized Prospective Trial: Single Port Laparoscopic Vertical Sleeve Gastrectomy Versus Conventional Five Port Laparoscopic Vertical Sleeve Gastrectomy Surgery

Not Applicable
Withdrawn
Conditions
Obesity
Nutrition Disorders
Body Weight
Registration Number
NCT01401426
Lead Sponsor
St. Luke's-Roosevelt Hospital Center
Brief Summary

Vertical Sleeve Gastrectomy has been shown to significantly reduce weight and has been approved as a treatment of morbid obesity. The standard laparoscopic operation requires five small incisions for the introduction of instruments and the band into the patient's abdomen. The investigators have developed a technique for performing this operation through a single incision at the belly button. This study compares this method to the conventional 5-incision approach.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • BMI >40
  • ASA I or II
Exclusion Criteria
  • Comorbid cardiac, pulmonary, renal, hepatic disease
  • Bleeding disorder
  • Previous gastric/esophageal surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Weight Loss1 month and 1 year
Secondary Outcome Measures
NameTimeMethod
Quality of life1 week and 3 months
Peri-Operative Complications1 month

Trial Locations

Locations (1)

St. Luke's Roosevelt Hospital Center

🇺🇸

New York, New York, United States

St. Luke's Roosevelt Hospital Center
🇺🇸New York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.